Navigation Links
12 science and technology tours being held in conjunction with Pittsburgh's G20 Summit

PITTSBURGH The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.

The Eds-Meds program will begin at 10:30 a.m. at Soldiers and Sailors Memorial auditorium, 4141 Fifth Ave., Oakland, with remarks by Carnegie Mellon President Jared L. Cohon, Pitt Chancellor Mark A. Nordenberg, and UPMC President and CEO Jeffrey A. Romoff. Tours will begin at noon, 2 p.m., and 4 p.m.

Tour sites are: Children's Hospital of UPMC, the Peter M. Winter Institute for Simulation, Education, and Research (WISER), Biomedical Science Tower 3, McGowan Institute for Regenerative Medicine, Center for Global Health, the Sports Performance Complex, the Robotics Institute, the Entertainment Technology Center, the Pitt Green Tour, the Center for Energy, the Quality of Life Technology Center, and the Intelligent Workplace.

Tours are for summit delegates and members of the media. Media interested in attending must have a photo ID from the media outlet they represent.


Contact: Morgan Kelly
University of Pittsburgh

Page: 1

Related medicine news :

1. Larta Institute Wins National Science Foundation (NSF) Contract
2. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
3. AED School Program at Its Best: Atlanta Public Schools Partnership With Cardiac Science
4. Greenberg Traurig Attorney Selected For Massachusetts Life Sciences Collaborative Task Force
5. Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity
6. Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time
7. Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial
8. Family Research Council President Tony Perkins Asks: Is This What President Obama Means by Robust Conscience Protections?
9. Derma Sciences Reports Second Quarter 2009 Results
10. Human Pheromone Sciences Announces Second Quarter Results
11. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
Post Your Comments:
Related Image:
12 science and technology tours being held in conjunction with Pittsburgh's G20 Summit
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
Breaking Medicine Technology: